Corrigendum to “Dietary carbohydrate restriction as the first approach in diabetes management: Critical review and evidence base” [Nutrition 31 (2015) 1-13] (Nutrition (2015) 31(1) (1–13), (S0899900714003323), (10.1016/j.nut.2014.06.011));Dietary carbohydrate restriction as the first approach in diabetes management: Critical review and evidence base

Nutrition

Volumn 31, Issue 1, 2015, Pages 1-13

  Feinman, Richard D ^a   Pogozelski, Wendy K ^b   Astrup, Arne ^c   Bernstein, Richard K ^d   Fine, Eugene J ^e   Westman, Eric C ^f   Accurso, Anthony ^g   Frassetto, Lynda ^h   Gower, Barbara A ⁱ   McFarlane, Samy I ^a   Nielsen, Jörgen Vesti ^j   Krarup, Thure ^k   Saslow, Laura ^l   Roth, Karl S ^m   Vernon, Mary C ⁿ   Volek, Jeff S ^o   Wilshire, Gilbert B ^p   Dahlqvist, Annika ^q   Sundberg, Ralf ^r   Childers, Ann ^s   Morrison, Katharine ^t   Manninen, Anssi H ^u   Dashti, Hussain M ^v   Wood, Richard J ^w   Wortman, Jay ^x   Worm, Nicolai ^y   more..

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d New York Diabetes Center   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f DUKE UNIVERSITY MEDICAL CENTER   (United States)

^g JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^j Bispebjerg University Hospital ^*  (Sweden)

^k BISPEBJERG HOSPITAL   (Denmark)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ Private Practice   (United States)

^o OHIO STATE UNIVERSITY   (United States)

^p Mid Missouri Reproductive Medicine and Surgery   (United States)

^q Hälsocentralen Centrum   (Sweden)

^r Private Practice   (Sweden)

^s Private practice   (United States)

^t Ballochmyle Medical Group   (United Kingdom)

^u Metabolia Oulu   (Finland)

^v KUWAIT UNIVERSITY   (Kuwait)

^w SPRINGFIELD COLLEGE   (United States)

^x First Nations Division   (Canada)

^y German University for Prevention and Health Care Management   (Germany)

more..

Author keywords

Carbohydrate; Diabetes; Hemoblobin A1c; Ketogenic diet; Low carbohydrate diet; Triglyceride

Indexed keywords

ACARBOSE; DISACCHARIDE; EXENDIN 4; GLIBENCLAMIDE; GLIMEPIRIDE; GLIPIZIDE; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; METFORMIN; MONOSACCHARIDE; PIOGLITAZONE; ROSIGLITAZONE; SATURATED FATTY ACID; SITAGLIPTIN; STARCH; TRIACYLGLYCEROL; CARBOHYDRATE DIET; GLUCOSE BLOOD LEVEL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); DIABETES CONTROL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; DRUG EFFICACY; DRUG SAFETY; EVIDENCE BASED MEDICINE; FAT INTAKE; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HIGH RISK PATIENT; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KETOGENIC DIET; LIPOPROTEIN BLOOD LEVEL; LOW CALORY DIET; LOW CARBOHYDRATE DIET; LOW FAT DIET; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PROTEIN INTAKE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW; THERAPY EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION; ADMINISTRATION AND DOSAGE; CARBOHYDRATE DIET; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DISEASE MANAGEMENT; METABOLISM;

BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIET, CARBOHYDRATE-RESTRICTED; DIETARY CARBOHYDRATES; DISEASE MANAGEMENT; EVIDENCE-BASED MEDICINE; HUMANS; HYPERGLYCEMIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; WEIGHT LOSS;

EID: 84922230039     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2018.12.002     Document Type: Erratum

References (99)

1. Westman E.C., Vernon M.C. Has carbohydrate-restriction been forgotten as a treatment for diabetes mellitus? A perspective on the ACCORD study design. Nutr Metab (Lond) 2008, 5:10.
2. Westman E.C., Yancy W.S., Humphreys M. Dietary treatment of diabetes mellitus in the preinsulin era (1914-1922). Perspect Biol Med 2006, 49:77-83.
3. Accurso A., Bernstein R.K., Dahlqvist A., Draznin B., Feinman R.D., Fine E.J., et al. Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal. Nutr Metab (Lond) 2008, 5:9.
4. Feinman R.D. Fad diets in the treatment of diabetes. Curr Diab Rep 2011, 11:128-135.
5. Volek J.S., Fernandez M.L., Feinman R.D., Phinney S.D. Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome. Prog Lipid Res 2008, 47:307-318.
6. Westman E.C., Yancy W.S., Mavropoulos J.C., Marquart M., McDuffie J.R. The effect of a low-carbohydrate, ketogenic diet versus a low-glycemic index diet on glycemic control in type 2-diabetes mellitus. Nutr Metab (Lond) 2008, 5:36.
7. Nutrition recommendations and interventions for diabetes-2013. Diabetes Care 2013, 36(Suppl 1):S12-32. American Diabetes Association.
8. Rizza R.A. Pathogenesis of fasting and postprandial hyperglycemia in type 2 diabetes: implications for therapy. Diabetes 2010, 59:2697-2707.
9. Gannon M.C., Hoover H., Nuttall F.Q. Further decrease in glycated hemoglobin following ingestion of a LoBAG30 diet for 10 wk compared with 5 wk in people with untreated type 2 diabetes. Nutr Metab (Lond) 2010, 7:64.
10. Gannon M.C., Nuttall F.Q. Control of blood glucose in type 2 diabetes without weight loss by modification of diet composition. Nutr Metab (Lond) 2006, 3:16.
11. Nuttall F.Q., Schweim K., Hoover H., Gannon M.C. Effect of the LoBAG30 diet on blood glucose control in people with type 2 diabetes. Br J Nutr 2008, 99:511-519.
12. Al-Khalifa A., Mathew T.C., Al-Zaid N.S., Mathew E., Dashti H. Low carbohydrate ketogenic diet prevents the induction of diabetes using streptozotocin in rats. Exp Toxicol Pathol 2011, 63:663-669.
13. Dashti H.M., Mathew T.C., Khadada M., Al-Mousawi M., Talib H., Asfar S.K., et al. Beneficial effects of ketogenic diet in obese diabetic subjects. Mol Cell Biochem 2007, 302:249-256.
14. Hussain T.A., Mathew T.C., Dashti A.A., Asfar S., Al-Zaid N., Dashti H.M. Effect of low-calorie versus low-carbohydrate ketogenic diet in type 2 diabetes. Nutrition 2012, 28:1016-1021.
15. Sonksen P., Sonksen J. Insulin: understanding its action in health and disease. Br J Anaesth 2000, 85:69-79.
16. Trends in intake of energy and macronutrients-United States: 1971 to 2000. JAMA 2004, 291:1193-1194. Centers for Disease Control and Prevention.
17. Gross L.S., Li L., Ford E.S., Liu S. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 2004, 79:774-779.
18. Carden T.J., Carr T.P. Food availability of glucose and fat, but not fructose, increased in the US between 1970 and 2009: analysis of the USDA food availability data system. Nutr J 2013, 12:130.
19. Trends in intake of energy and macronutrients-United States, 1971 to 2000. MMWR Morb Mortal Wkly Rep 2004, 53:80-82. Centers for Disease Control and Prevention.
20. Al-Khalifa A., Mathew T.C., Al-Zaid N.S., Mathew E., Dashti H.M. Therapeutic role of low-carbohydrate ketogenic diet in diabetes. Nutrition 2009, 25:1177-1185.
21. McFarlane S.I., Jacober S.J., Winer N., Kaur J., Castro J.P., Wui M.A., et al. Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers. Diabetes Care 2002, 25:718-723.
22. Stratton I.M., Kohner E.M., Aldington S.J., Turner R.C., Holman R.R., Manley S.E., et al. UKPDS 50: risk factors for incidence and progression of retinopathy in type II diabetes over 6 y from diagnosis. Diabetologia 2001, 44:156-163.
23. Dyson P.A., Beatty S., Matthews D.R. A low-carbohydrate diet is more effective in reducing body weight than healthy eating in both diabetic and non-diabetic subjects. Diabet Med 2007, 24:1430-1435.
24. Howard B.V., Manson J.E., Stefanick M.L., Beresford S.A., Frank G., Jones B., et al. Low-fat dietary pattern and weight change over 7 y: the Women's Health Initiative dietary modification trial. JAMA 2006, 295:39-49.
25. Dansinger M.L., Schaefer E.J. Low-fat diets and weight change. JAMA 2006, 295:94-95.
26. Howard B.V., Van Horn L., Hsia J., Manson J.E., Stefanick M.L., Wassertheil-Smoller S., et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative randomized controlled dietary modification trial. JAMA 2006, 295:655-666.
27. Tinker L.F., Bonds D.E., Margolis K.L., Manson J.E., Howard B.V., Larson J., et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Arch Intern Med 2008, 168:1500-1511.
28. Atkins R.C. Dr. Atkins' new diet revolution 2002, Avon Books, New York.
29. Westman E.C., Phinney S.D., Volek J. The new Atkins for a new you: the ultimate diet for shedding weight and feeling great forever 2010, Simon & Schuster, New York.
30. Eades M.R., Eades M.D. Protein power 1996, Bantam Books, New York.
31. Foster G.D., Wyatt H.R., Hill J.O., Makris A.P., Rosenbaum D.L., Brill C., et al. Weight and metabolic outcomes after 2 y on a low-carbohydrate versus low-fat diet: a randomized trial. Ann Intern Med 2010, 153:147-157.
32. Foster G.D., Wyatt H.R., Hill J.O., McGuckin B.G., Brill C., Mohammed B.S., et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2003, 348:2082-2090.
33. Gunnars, K. Low-Carb Diets - Healthy, but Hard to Stick to? In: Authority Nutrition. 2013. Available at. Accessed September 6, 2014. http://AuthorityNutrition.com.
34. Belza A., Ritz C., Sorensen M.Q., Holst J.J., Rehfeld J.F., Astrup A. Contribution of gastroenteropancreatic appetite hormones to protein-induced satiety. Am J Clin Nutr 2013, 97:980-989.
35. Feinman R.D., Vernon M.C., Westman E.C. Low carbohydrate diets in family practice: what can we learn from an internet-based support group. Nutr J 2006, 5:26.
36. Santos F.L., Esteves S.S., da Costa Pereira A., Yancy W.S., Nunes J.P. Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. Obes Rev 2012, 13:1048-1066.
37. Krieger J.W., Sitren H.S., Daniels M.J., Langkamp-Henken B. Effects of variation in protein and carbohydrate intake on body mass and composition during energy restriction: a meta-regression 1. Am J Clin Nutr 2006, 83:260-274.
38. Feinman R.D., Fine E.J. "A calorie is a calorie" violates the second law of thermodynamics. Nutr J 2004, 3:9.
39. Feinman R.D., Fine E.J. Nonequilibrium thermodynamics and energy efficiency in weight loss diets. Theor Biol Med Model 2007, 4:27.
40. Keys A. Coronary heart disease in seven countries. 1970;41 Suppl:1-211.
41. Keys A. Atherosclerosis: a problem in newer public health. J Mt Sinai Hosp N Y 1953, 20:118-139.
42. Anderson K.M., Castelli W.P., Levy D. Cholesterol and mortality. 30 y of follow-up from the Framingham study. JAMA 1987, 257:2176-2180.
43. Siri-Tarino P.W., Sun Q., Hu F.B., Krauss R.M. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am J Clin Nutr 2010, 91:535-546.
44. Siri-Tarino P.W., Sun Q., Hu F.B., Krauss R.M. Saturated fat, carbohydrate, and cardiovascular disease. Am J Clin Nutr 2010, 91:502-509.
45. Weinberg S.L. The diet-heart hypothesis: a critique. J Am Coll Cardiol 2004, 43:731-733.
46. Ravnskov U., Rosch P.J., Sutter M.C., Houston M.C. Should we lower cholesterol as much as possible?. Bmj 2006, 332:1330-1332.
47. Yancy W.S., Westman E.C., French P.A., Califf R.M. Diets and clinical coronary events: The truth is out there. Circulation 2003, 107:10-16.
48. Teicholz N. The big fat surprise. Why butter, meat & cheese belong in a healthy diet 2014, Simon & Schuster, New York.
49. Kendrick M. The great cholesterol con: the truth about what really causes heart disease and how to avoid it 2008, John Blake, London.
50. Ravnskov U. The cholesterol myths: exposing the fallacy that cholesterol and saturated fat cause heart disease 2000, NewTrends Publishing, Inc., Washington, DC.
51. Taubes G. Good calories, bad calories 2007, Alfred A. Knopf, New York.
52. Steinberg D. The cholesterol wars: the skeptics versus the preponderance of evidence 2007, Academic Press, San Diego, Calif.
53. Jakobsen M.U., O'Reilly E.J., Heitmann B.L., Pereira M.A., Balter K., Fraser G.E., et al. Major types of dietary fat and risk of coronary heart disease: a pooled analysis of 11 cohort studies. Am J Clin Nutr 2009, 89:1425-1432.
54. Mozaffarian D., Rimm E.B., Herrington D.M. Dietary fats, carbohydrate, and progression of coronary atherosclerosis in postmenopausal women. Am J Clin Nutr 2004, 80:1175-1184.
55. Chowdhury R., Warnakula S., Kunutsor S., Crowe F., Ward H.A., Johnson L., et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 2014, 160:398-406.
56. Minger D. Death by food pyramid: how shoddy science, sketchy politics and shady special interests have ruined our health 2014, Primal Nutrition, Inc., New York.
57. Clarke R., Frost C., Collins R., Appleby P., Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997, 314:112-117.
58. Posner B.M., Cobb J.L., Belanger A.J., Cupples L.A., D'Agostino R.B., Stokes J. Dietary lipid predictors of coronary heart disease in men. The Framingham Study. Arch Intern Med 1991, 151:1181-1187.
59. Lin J., Wu P.H., Tarr P.T., Lindenberg K.S., St-Pierre J., Zhang C.Y., et al. Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1 alpha null mice. Cell 2004, 119:121-135.
60. Forsythe C.E., Phinney S.D., Feinman R.D., Volk B.M., Freidenreich D., Quann E., et al. Limited effect of dietary saturated fat on plasma saturated fat in the context of a low carbohydrate diet. Lipids 2010, 45:947-962.
61. Forsythe C.E., Phinney S.D., Fernandez M.L., Quann E.E., Wood R.J., Bibus D.M. Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation. Lipids 2008, 43:65-77.
62. Volek J.S., Phinney S.D., Forsythe C.E., Quann E.E., Wood R.J., Puglisi M.J., et al. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids 2009, 44:297-309.
63. Lin J., Yang R., Tarr P.T., Wu P.H., Handschin C., Li S., et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1 beta coactivation of SREBP. Cell 2005, 120:261-273.
64. Borghjid S., Feinman R.D. Response of C57 Bl/6 mice to a carbohydrate-free diet. Nutr Metab (Lond) 2012, 9:69.
65. Stratton I.M., Adler A.I., Neil H.A., Matthews D.R., Manley S.E., Cull C.A., et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000, 321:405-412.
66. Turner R.C. The U.K. Prospective Diabetes Study. A review. Diabetes Care 1998, 21(Suppl 3):C35-38.
67. Turner R.C., Millns H., Neil H.A., Stratton I.M., Manley S.E., Matthews D.R., et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). BMJ 1998, 316:823-828.
68. Orchard T.J., Forrest K.Y., Ellis D., Becker D.J. Cumulative glycemic exposure and microvascular complications in insulin-dependent diabetes mellitus. The glycemic threshold revisited. Arch Intern Med 1997, 157:1851-1856.
69. Volek J.S., Feinman R.D. Carbohydrate restriction improves the features of metabolic syndrome. Metabolic syndrome may be defined by the response to carbohydrate restriction. Nutr Metab (Lond) 2005, 2:31.
70. Jenkins D.J., Kendall C.W., McKeown-Eyssen G., Josse R.G., Silverberg J., Booth G.L., et al. Effect of a low-glycemic index or a high-cereal fiber diet on type 2 diabetes: a randomized trial. JAMA 2008, 300:2742-2753.
71. Barter P.J., Ballantyne C.M., Carmena R., Castro Cabezas M., Chapman M.J., Couture P., et al. Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: Report of the thirty-person/ten-country panel. JIntern Med 2006, 259:247-258.
72. Dreon D.M., Fernstrom H.A., Campos H., Blanche P., Williams P.T., Krauss R.M. Change in dietary saturated fat intake is correlated with change in mass of large low-density-lipoprotein particles in men. Am J Clin Nutr 1998, 67:828-836.
73. Dreon D.M., Fernstrom H.A., Williams P.T., Krauss R.M. A very low-fat diet is not associated with improved lipoprotein profiles in men with a predominance of large, low-density lipoproteins. Am J Clin Nutr 1999, 69:411-418.
74. McLaughlin T., Reaven G., Abbasi F., Lamendola C., Saad M., Waters D., et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease?. Am J Cardiol 2005, 96:399-404.
75. Feinman R.D., Volek J.S., Westman E. Dietary carbohydrate restriction in the treatment of diabetes and Mmtabolic syndrome. Clin Nutr Insight 2008, 34:1-5.
76. Iso H., Naito Y., Kitamura A., Sato S., Kiyama M., Takayama Y., et al. Serum total cholesterol and mortality in a Japanese population. J Clin Epidemiol 1994, 47:961-969.
77. Saito N., Sairenchi T., Irie F., Iso H., Iimura K., Watanabe H., et al. Low serum LDL cholesterol levels are associated with elevated mortality from liver cancer in Japan: the Ibaraki Prefectural health study. Tohoku J Exp Med 2013, 229:203-211.
78. Nielsen J.V., Gando C., Joensson E., Paulsson C. Low carbohydrate diet in type 1 diabetes, long-term improvement and adherence: a clinical audit. Diabetol Metab Syndr 2012, 4:23.
79. Bernstein R.K. Dr. Bernstein's diabetes solution: the complete guide to achieving normal blood sugars 2011, Little, Brown and Co, New York. 4th ed.
80. Saslow L.R., Kim S., Daubenmier J.J., Moskowitz J.T., Phinney S.D., Goldman V., et al. A randomized pilot trial of a moderate carbohydrate diet compared with a very low carbohydrate diet in overweight or obese individuals with type 2 diabetes mellitus or prediabetes. PLoS One 2014, 9:e91027.
81. Yancy W.S., Foy M., Chalecki A.M., Vernon M.C., Westman E.C. A low-carbohydrate, ketogenic diet to treat type 2 diabetes. Nutr Metab (Lond) 2005, 2:34.
82. Nielsen J.V., Joensson E. Low-carbohydrate diet in type 2 diabetes. Stable improvement of bodyweight and glycemic control during 22 mo follow-up. Nutr Metab (Lond) 2006, 3:22.
83. Nielsen J.V., Jonsson E., Nilsson A.K. Lasting improvement of hyperglycaemia and bodyweight: low-carbohydrate diet in type 2 diabetes-a brief report. Ups J Med Sci 2005, 110:69-73.
84. Boden G., Sargrad K., Homko C., Mozzoli M., Stein T.P. Effect of a low-carbohydrate diet on appetite, blood glucose levels, and insulin resistance in obese patients with type 2 diabetes. Ann Intern Med 2005, 142:403-411.
85. Gerstein H.C., Miller M.E., Byington R.P., Goff D.C., Bigger J.T., Buse J.B., et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358:2545-2559.
86. Nissen S.E. Perspective: effect of rosiglitazone on cardiovascular outcomes. Curr Cardiol Rep 2007, 9:343-344.
87. Nissen S.E., Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007, 356:2457-2471.
88. Diamond G.A., Bax L., Kaul S. Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular death. Ann Intern Med 2007, 147:578-581.
89. Kaul S., Diamond G.A. Diabetes: breaking news! Rosiglitazone and cardiovascular risk. Nat Rev Cardiol 2010, 7:670-672.
90. Taubes G. The soft science of dietary fat. Science 2001, 291:2536-2545.
91. Martin W.F., Armstrong L.E., Rodriguez N.R. Dietary protein intake and renal function. Nutr Metab (Lond) 2005, 2:25.
92. Lustig R.H. Fructose: metabolic, hedonic, and societal parallels with ethanol. J Am Diet Assoc 2010, 110:1307-1321.
93. Lustig R.H., Schmidt L.A., Brindis C.D. Public health: the toxic truth about sugar. Nature 2012, 482:27-29.
94. Taubes G., Couzens C.K. Big sugar's sweet little lies 2012, Foundation for National Progress, Mother Jones San Francisco, CA.
95. Stanhope K.L., Havel P.J. Fructose consumption: recent results and their potential implications. Ann N Y Acad Sci 2010, 1190:15-24.
96. Feinman R.D., Fine E.J. Perspective on fructose. Nutr Metab (Lond) 2013, 9.
97. Gannon M.C., Nuttall F.Q., Westphal S.A., Fang S., Ercan-Fang N. Acute metabolic response to high-carbohydrate, high-starch meals compared with moderate-carbohydrate, low-starch meals in subjects with type 2 diabetes. Diabetes Care 1998, 21:1619-1626.
98. Foster K., Huber P. Judging science. Scientific knowledge in the federal courts 1999, MIT Press, Cambridge, MA.
99. Smith G.C., Pell J.P. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ 2003, 327:1459-1461.